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Abstract 
Background: Dysbiosis has been recently demonstrated in AS patients but its implications 
in the modulation of intestinal immune responses have been never studied. The aim of this 
study was to investigate the role of ileal bacteria in modulating local and systemic immune 
responses in Ankylosing Spondylitis (AS). 
Methods: Ileal biopsies were obtained from 50 HLA-B27+ AS patients and 20 normal 
subjects. Silver stain was used to visualize bacteria. Ileal expression of tight and adherens 
junction proteins was investigated by TaqMan real-time (RT-PCR) and 
immunohistochemistry. Serum levels of lipopolysaccharide (LPS), LPS-binding protein 
(LPS-BP), intestinal fatty acid-binding protein (iFABP) and zonulin were assayed by 
ELISA. Monocyte immunological functions were studied in in vitro experiments. In addition 
the effects of antibiotics on tight junctions in HLA-B27 transgenic (TG) rats were assessed. 
Results: Adherent and invasive bacteria were observed in the gut of AS patients with the 
bacterial scores significantly correlated with gut inflammation. Impairment of the gut-
vascular barrier was also present in AS, accompanied by significant up-regulation of 
zonulin, and associated with high serum levels of LPS, LPS-BP, iFABP and zonulin. In in 
vitro studies zonulin altered endothelial tight junctions while its epithelial release was 
modulated by isolated AS ileal bacteria. AS circulating monocytes displayed an anergic 
phenotype partially restored by ex vivo stimulation with LPS+sCD14 and their stimulation 
with recombinant zonulin induced a clear M2 phenotype. Antibiotics restored tight junction 
function in HLA-B27 TG rats. 
Conclusions: Bacterial ileitis, increased zonulin expression and damaged intestinal 
mucosal- and gut-vascular barriers, characterizes the gut of AS patients and are 
associated with increased blood levels of zonulin, and bacterial products. Bacterial 
products and zonulin influence monocyte behavior.  
Keywords: dysbiosis; zonulin; epithelial barrier; vascular barrier; Ankylosing Spondylitis  
Introduction  
In healthy subjects, the gastrointestinal tract is colonized by a broad range of microbes, 
termed the gut microbiota.[1] In heathy individuals a gut-epithelial [2] and a gut-vascular 
barrier [3] control the translocation of bacteria and bacterial antigens into the bloodstream. 
The homeostasis of normal microbial flora in the gut is essential for intestinal health and its 
altered balance, termed dysbiosis, may influence intestinal permeability through the 
release of zonulin,[4] a protein that modulates the permeability of epithelial tight junctions 
of the digestive tract.  
Dysbiosis has been recently demonstrated in the terminal ileum of AS patients togheter 
with the presence of subclinical gut inflammation.[5] It is unclear, however, whether this 
dysbiosis is a cause or consequence of the inflammation and whether dysbiosis modulates 
immune responses in AS. The aim of the present study was to study the tissue localization 
of bacteria in the gut of AS patients and the eventual changes in gut-epithelial and gut-
vascular barriers integrity. We also assessed the role of zonulin in modulating intestinal 
permeability and monocyte activation. Finally, we analyzed whether alterations in gut 
permeability and microbiota composition are associated with systemic immune responses.  
 
 
 
 
 
 
 
 
 
 
Methods 
Consent was obtained from all enrolled subjects and the study was approved  from the 
institute review board at the Universities of Palermo and Ghent. For more details about 
patients and controls see supplemental methods and supplemental table I.  
Histomorphological grading and immunohistochemistry 
One hundred and sixty-five biopsies were obtained from the 50 AS patients enrolled. Gut 
specimens from patients with AS were histologically divided as previously described in: 
normal gut histology, acute and chronic inflammation.[6-7] The degree of gut inflammation 
was also evaluated by using IL-8 as a general marker of inflammation.[8] For more details 
about bacteria characterization and immunohistochemistry see supplemental methods.  
Isolation of bacteria 
Ileal biopsy specimens from patients and controls enrolled at the University of Palermo, 
were immediately processed for bacteriological study in the Microbiology Laboratory, 
Azienda Ospedaliera Villa Sofia Cervello, Palermo, Italy according to Conte et al. [9] For 
more information, see supplemental methods.  
Cultures for aerobic and facultative anaerobic bacteria  
For bacterial culteres only ileal biopsies obtained from AS patients and controls enrolled at 
the University of Palermo were used. For more information, see supplemental methods. 
RNA extraction and quantitative TaqMan real-time PCR (RT-PCR)  
Total RNA was extracted using the Qiagen RNeasy Mini kit, with on-column DNase I 
digestion as previously described.[7] For more information, see supplemental methods.  
Flow cytometry analysis of surface and intracellular antigens 
PBMCs were isolated from the peripheral blood of 20 patients with AS and 10 healthy 
controls as previously described.[7] A list of the antibodies used is provided in 
supplemental table 2.  
ELISA for circulating LPS, iFABP and zonulin 
Levels of PGE2 were analyzed in sera of all AS patients and controls. For more 
information, see supplemental methods.  
Cell cultures 
In order to evaluate the role of intestinal bacteria isolated from AS patients in modulating 
epithelial zonulin levels, bacteria were isolated from ileal AS samples obtained from 
patients enrolled at the University of Palermo as described by Conte MP et al [9] and 
incubated with Caco-2 epithelial cells. The modulation of zonulin mRNA was then 
assessed by RT-PCR. The effect of zonulin on human umbilical vein endothelial cells 
(HUVECs) and peripheral blood mononuclear cells (PBMC) was evaluated as previously 
described.[9] For more information, see supplemental methods.  
HLA-B27 TG rats 
HLA-B*2705 transgenic rats of line 33-3 (B27-TG) on a Fischer background (F344/NTac-
Tg (HLA-B*2705, β2M) (Taconic, Hudson, NY) were backcrossed with PVG rats 
(PVG/OlaHsd) (Harlan, UK) for a minimum of ten generations before their use in 
experiments as previously described.[10] For more information, see supplemental 
methods.  
Statistical analysis 
The non-parametric Mann–Whitney test was used to calculate the statistical significance 
between groups. Spearman’s rank correlation was used to calculate the correlation 
between different variables in AS. p values <0.05 were considered significant. 
 
 
 
 
 
 
Results 
Assessment of intestinal gut inflammation in AS 
IL-8 was over-expressed in AS patients with chronic inflammation (Supplemental figure 
1C-D) compared to those with acute inflammation (Supplemental figure 1B-D) and without 
inflammation (Supplemental figure 1D) and controls (Supplemental figure 1A and D). In AS 
patients, the number of IL-8 positive cells was correlated with the degree of intestinal 
inflammation (Supplemental figure 1D). 
Adherent and invasive bacteria are present in the gut of AS patients  
Adherent and invading rod-shaped bacteria were observed in 35 out of 50 AS patients 
(25/33 of the Palermo cohort and 10/17 of the Gent cohort) independent of the presence of 
acute or chronic inflammation. Among these patients, only 4 showing acute inflammation 
and 4 showing chronic inflammation were taking sulfasalazine. Of these, 2 out of 4 
patients with acute inflammation and 1 out of 4 with chronic inflammation did not show 
cultivable bacteria. Bacteria were mainly detected within the epithelium and rarely in the 
context of lamina propria (Figure 1A-C). Absence of adherent and/or invasive bacteria was 
observed in normal ileum (Figure 1D). In particular, invasive bacteria, sometimes 
aggregated in clusters, were observed in 12 AS patients of the Palermo’s cohort and in 7 
AS patients of the Gent’s cohort. The bacterial scores significantly correlated with the 
percentages of infiltrating inflammatory cells (r2=0.57, p<0.0001) (Figure 1E). Gram+ (F-G) 
and Gram- (H-I) bacteria were confirmed to be both adherent and invasive in AS patients. 
The presence of invasive bacteria in AS was invariably associated with histologic changes 
characterized by the detachment of basal membranes from the lamina propria, forming 
vacuoles inside the villi, and edematous lamina propria with extravasated red blood cells 
(Figure 1K-M and Supplemental Table 3). Isolated edematous lamina propria, without 
detachment of basal membranes and/or vasculitis, was observed in the intestine of all 
patients displaying adherent bacteria (Supplemental Table 3). Identification of the bacteria 
from culture of ileal samples showed that all of AS patients of the Palermo’s cohort had 
cultivable bacteria essentially the Gram-negative bacteria Escherechia coli and Prevotella 
spp (Figure 1N). Conversely, only 5 out of 20 control samples displayed cultivable bacteria 
(25%) being Escherichia coli the only Gram-negative species found (Figure 1N). No 
culture of ileal samples was performed in ileal samples from the Gent’s cohort. Cultures of 
Prevotella and Escherichia coli were confirmed by PCR. 
We next studied the expression of intestinal tight junction proteins. A significant down-
regulation of claudin 1 (Figure 1O), claudin 4 (Figure 1P), occludin (Figure 1Q) and zonula 
occludens 1 (Figure 1R) was observed in the gut of AS patients (expecially in those with 
chronic gut inflammation) compared to controls. The significant down-regulation of the tight 
junction proteins in AS was confirmed by IHC demonstrating the reduced expression in AS 
of occludin (Figure 2A, C) and claudin 4 (Figure 2D, F) compared to controls (Figure 2B, C 
and Figure 2E, F).  
Zonulin is up-regulated in the gut of AS patients and modulated by ileal bacteria 
We next evaluated zonulin expression in the biopsies of all AS patients and controls. 
Significant up-regulation of zonulin mRNA was observed in the ileal samples of AS 
patients, expecially in those with chronic gut inflammation, (Figure 2G), inversely 
correlated with the expression levels of claudin 1 (r2=0.28,p<0.0001) (Supplemental Figure 
1E), claudin 4 (r2=0.324, p<0.0001) (Supplemental Figure 1F), occludin (r2=0.654, 
p>0.0001) (Supplemental Figure 1G) and zonula occludens 1 (r2=0.245; p<0.001) 
(Supplemental Figure 1H). Zonulin has been identified as pre-haptoglobin 2, one of the 
two genetic variants (together with haptoglobin-1) of human haptoglobins.[3] Since that by 
RT-PCR we can not completely discriminate between pre-HP2 and HP2,[11] over-
expression of zonulin was also confirmed by immunohistochemistry in frozen ileal samples 
obtained from AS patients by using a specific anti-zonulin antibody (Figure 2 H-J). Analysis 
of tissue distribution of zonulin demonstrated its expression among epithelial cells and 
infiltrating mononuclear cells (Figure 2 H-I). Interestingly, the number of zonulin+ cells 
correlated with the number of IL-8+ cells (Figure 2K). We next evaluated in vitro the role of 
isolated ileal bacteria from AS patients in modulating zonulin expression. As shown in 
Figure 2L, co-culture of Caco-2 cells with bacteria isolated from ileal biopsies of 5 AS 
patients of the Palermo’s cohort induced significant up-regulation of zonulin. 
Impairment of gut-vascular barrier occurs in AS patients 
In order to evaluate whether increased intestinal permeability was paralleled by 
impairment of the gut vascular barrier (GVB),[12] RT-PCR for junctional adhesion 
molecule-A (JAM-A), a vascular tight junctions protein, VE-cadherin, a vascular adherens 
junctions protein, and PV1, a marker of endothelial cells permeability, was performed.  VE-
cadherin and JAM-A (Figure 3A-B), were significantly down-regulated in the the inflamed 
ileum of AS patients togheter with a significant up-regulation of PV1 expecially in those 
patients with chronic gut inflammation compared to controls (Figure 3C). To confirm the 
alteration of GVB, confocal microscopy analysis of occludin and CD31 (a specific 
endothelial cell marker) expression and of CD31/GFAP/PV1 was next performed in ileal 
samples from AS patients and controls. As shown in Figure 3 D-F, endothelial occludin 
expression in HC showed a continuous staining of the junctional protein that surrounded 
cell borders. In comparison, endothelial cells from AS patients exhibited the 
disappearance of the classic Occludin continuous staining, showing a jagged and broken 
vascular distribution (Figure 3G-I). Analysis of GVB showed in AS a higher expression of 
PV1 (Figure 3N) compared to HC (Figure 3J) and confirmed the disorganized staining for 
CD31 (Figure 3O) and GFAP (Figure 3P).  
Zonulin alters the expression of endothelial tight junctions  
We next evaluated in vitro whether zonulin may influence the expression of endothelial 
tight junction proteins. As shown in figure 4, zonulin induced a significant down-regulation 
of occludin (Figure 4A) and VE-cadherin (Figure 4B). Corresponding with the alteration of 
the GVB, increased serum zonulin levels (Figure 4C) were observed in AS. To establish 
whether serum zonulin levels are correlated with intestinal permeability, LA/MA urine ratio 
was determined in 20 AS patients and 20 controls, all enrolled at the University of 
Palermo. An increased intestinal permeability, significantly correlated with serum zonulin, 
was present in AS patients (LA/MA 0.052 ± 0.002, r2=0.7236, p=0.01777) (Figure 4D) but 
not in healthy control (LA/MA 0.021 ± 0.0011; r2=0.1858; p>0.05) (data not shown). 
Zonulin has a CD163 binding motif identical to that present in mature haptoglobin 2 [9,13] 
In order to assess the potential functional relevance of zonulin interaction with CD163, 
isolated PBMC from AS patients and controls were incubated with recombinant zonulin. As 
shown in Figure 4E-F and G-H, incubation with zonulin induced a significant expansion in 
of c-MAF+CD163+ cells identified as M2 polarized macrophages [14] in AS (Figure 4 E-F) 
but not in controls (Figure 4G-H). 
Increased serum levels of iFABP, LPS and LPS-BP are found in AS patients 
Since the alterations of epithelial and endothelial permeability, we next evaluated the 
serum levels of LPS, LPS-BP and iFABP in all the AS patients and controls. As shown in 
figure 5, significantly increased levels of LPS (Figure 5A), LPS-BP (figure 5B) and iFABP 
(Figure 5C) were observed in AS patients. Since it has been demonstrated that the 
presence of high LPS concentration down-regulates the expression of CD14,[15] we 
examined by flow cytometry, the expression of CD14 in circulating monocytes and the 
effects of LPS and soluble CD14 stimulation on IL-23 production. A significant reduction of 
CD14+ monocytes (Figure 5D-F) but also of HLADR+ monocytes (Figure 5G-H) was 
observed only in AS monocytes. Since the soluble form of CD14 (sCD14) has been 
demonstrated to enable CD14- cells to respond to LPS [16], we next evaluated whether 
sCD14 might rescue AS CD14- cells from their anergic state. Among AS CD14+ cells, 
stimulation with LPS, but not with sCD14, modified the expression of IL-23 that was not 
further modified by the combination of LPS and sCD14 (Figure 5I-K). Conversely, only the 
combination of sCD14 and LPS strongly up-regulated the production of IL-23 in AS CD14 
negative monocytes (Figure 5I-K).  
Alteration of epithelial tight junctions occurs in HLA-B27 rats and is restored by antibiotic 
treatment 
In human HLA–B27 and β2-microglobulin transgenic rats (B27-TG), ileitis develops 
spontaneously.[17] In order to study whether alteration of tight junctions is present in the 
ileal samples of these rats, ileal samples from 5 HLA-B27 TG and 5 wild type (WT) rats 
were evaluated. HA-B27 rats displayed ileal inflammation characterized by IL-23 increased 
expression (Figure 6B), occludin down-regulation (Figure 6F) and the presence of 
adherent bacteria (Figure 6J). After antibiotic treatment caused a significant amelioration 
of signs of intestinal inflammation as previously described,[18] the reduction of IL-23 
expression (Figure 6C-D), the normalization of occludin expression (Figure 6G-H) and the 
disappearance of adherent bacteria (Figure 6K-L).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Discussion 
In this study we demonstrate that adherent and invading bacteria are present in the ileum 
of AS patients and are associated with the alteration of epithelial and gut-vascular barriers. 
The presence of leaky epithelium and endothelium in AS ileum is accompanied by the 
translocation of zonulin and bacterial products into bloodstream possibly inducing the 
modulation of the innate immune system in AS. 
The intestinal microbiota plays a critical role in modulating the immune response of the 
gut.[19] The potential role of intestinal bacteria in the pathogenesis of gut inflammation in 
SpA patients has been highlighted by the identification of dysbiosis in different SpA 
subsets, including AS patients.[5, 20-21] However, the question of how dysbiosis can 
influence local and systemic immune responses in AS has not yet been explored.  
In this study we confirm and expand our previous results [5] by demonstrating that Gram 
negative bacteria, essentially Escherichia Coli and Prevotella spp, and Gram+ bacteria are 
present in AS ileal samples, displaying both adherent and invasive behavior. Interestingly, 
the presence of invasive bacteria was associated with specific histologic alterations mainly 
characterized by the detachment of basal membrane from lamina propria, leading to the 
formation of vacuoles inside the villi and hemorrhagic extravasation. These histologic 
findings seem to be directly attributable to the presence of bacteria since similar histologic 
alterations have previously been reported in mice infected with enteropathogenic 
Escherichia coli.[22] 
In the presence of pathogenic or non-pathogenic enteric bacteria, mammalian small 
intestines activate the zonulin pathway [3] that is involved in the regulation of the 
permeability of epithelial tight junctions.[4] In our study, tissue levels of zonulin were 
significantly up-regulated in AS ileal samples and accompanied by IL-8 over-expression 
and a profound reduced expression of tight junction proteins by epithelial cells. These 
alterations were dependent of the degree of intestinal inflammation, associated with both 
adherent and invasive bacteria and apparently related to a reduced expression by 
epithelial cells. We, however, cannot exclude that loss of epithelial cells may also 
contribute to the reduced tight junction protein expression. Serum zonulin increase was 
also observed in AS patients with more pronounced gut inflammation, accompanied by an 
increased intestinal permeability evaluated by LA/MA urine ratio. Interestingly, isolated 
bacteria from AS ileal biopsies significantly up-regulated zonulin expression in cultured 
epithelial cells, apparently indicating a specific effect of AS associated bacteria. It is 
unclear whether these alterations are the cause or the consequence of intestinal 
dysbiosis. However, here we demonstrated that alterations of tight junctions, also present 
in HLA-B27 TG rats, are restored after antibiotic treatments and that antibiotics therapy 
reduced epithelium-adherent bacteria, suggesting that intestinal dysbiosis might be 
responsible for the impairment of the epithelial barrier. The reduced number of adherent 
intestinal bacteria we observed is consistent with previous studies demonstrating that 
antibiotic treatment reduces mucosal adherent bacteria in mice.[18] 
Together with gut-epithelial barrier, a GVB has been recently demonstrated in mice and 
humans, that acts by preventing the entry into the bloodstream of microbiota-derived 
products.[12] The GVB shows adherens junctions and tight junctions that seem to be 
modulated or down-regulated, as demonstrated in our in vitro experiments, by zonulin. 
Increased zonulin expression was in fact accompanied by a significant down-regulation of 
endothelial tight junction proteins, such as occludin, and vascular adherens proteins such 
as VE-Cadherin and by the up-regulation of PV1, a marker of increased endothelial 
permeability.[23] The presence of a “leaky endothelium” was also confirmed by confocal 
microscopy experiments showing disorganized staining for CD31, occludin and GFAP and 
by the demonstration of increased serum levels of zonulin and bacterial products such as 
LPS, iFABP and LPS-BP in AS patients’ serum. Overall, our results point to a zonulin-
dependent epithelial and endothelial loss of barrier function. The fact that gene expression 
analysis cannot distinguish between pre-HP2 (alias zonulin) and Hp2 and that antibodies 
used for the IHC experiments may not be specific enough to exclusively detect zonulin and 
not mature HP2 may raise the possibility that HP2 rather than zonulin is upregulated. 
However, the decreased expression of tight junction protein and, most importantly the 
direct correlation between zonulin and LA/MA point clearly to the involvement of zonulin 
and not the mature HP2 that has never been reported to have an effect on barrier function. 
Zonulin has a CD163 binding motif identical to that present in mature haptoglobin 2 [9] that 
has been shown to bind the haptoglobin receptor CD163.[13] Therefore, it is conceivable 
that zonulin binds to CD163 as well as haptoglobin. The potential functional relevance of 
this binding in the regulation of monocytes behavior, however, has been not previously 
studied. Here we demonstrated that zonulin induces a significant in vitro expansion of 
CD163+cMAF+ monocytes, compatible with the M2 phenotype, and that these cells were 
expanded in the peripheral blood of AS patients. Macrophages play essential activities in 
homeostasis maintenance during different organism's conditions and may be polarized 
according to various stimuli into distinct populations. M2 macrophages are macrophages 
essentially  involved in the pathogenesis of asthma, fibrosis, atopic dermatitis, cancer and 
granuloma formation.[24] Furthermore, an increased frequency of CD163+M2 monocytes, 
producing IL-23, has been previously demonstrated to be expanded in the peripheral 
blood and inflamed gut and synovial tissues of AS patients.[25-26] The in vitro stimulation 
of AS PBMC with recombinant zonulin, was also accompanied by a significant expansion 
of cMAF+CD163+ M2 cells. We also observed the zonulin-dependent expansion of c-
MAF+CD163- cells. Beyond its role in modulating macrophage differentiation, c-MAF is 
also involved in the differentiation of Th17 cells [27-28] and we cannot exclude that zonulin 
might induce also the expansion of c-MAF+ T cells.  
We also studied the functional relevance of the increased circulating levels of bacterial 
products in AS. In the gut, the presence of high LPS concentrations down-regulates the 
monocyte expression of CD14, the receptor involved in the binding of LPS/LPS-BP 
complex.[15] Increased LPS levels, in AS, were accompanied by the down-regulation of 
CD14 on the surface of monocytes together with the reduced expression of HLA-DR. 
CD14-HLADR- monocytes have been demonstrated to be functionally anergic [29] and this 
anergic phenotype was rescued, at least in part, by the co-incubation of these cells with 
LPS+sCD14 leading to an increased expression of IL-23. 
In conclusion, in this study we provide the first evidence that adherent and invasive 
bacteria are present in the inflamed gut of AS patients and that these bacteria, through the 
release of zonulin, may induce a leaky gut epithelial and endothelial barrier, leading to the 
translocation of intestinal derived proteins into bloodstream, ultimately inducing systemic 
immune alterations that might participate in AS pathogenesis.  
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Figure legends 
Figure 1. Invasive and adherent bacteria are present in the ileum of AS patients and 
are associated with alterations of tight junction proteins. A-D representative 
microphotographs showing adherent (A) and invasive (B-C) bacteria in AS but not in 
controls (D). E bacterial scores are directly correlated with with the number of infiltrating 
mononuclear cells. F-G: representative images showing Gram staining in AS patients 
demonstrating the presence of invading Gram+ bacteria. H-J: representative images 
showing immunohistochemistry for LPS in AS patients (H-I) and controls (J). K-M: 
histologic alterations are associated with the presence of bacteria such as hemorrhages 
(K-L) and detachment of epithelium from basal membrane (M). N: Cultures of isolated 
bacteria displayed mainly E Coli and Prevotella. O-R: relative m-RNA levels of Claudin1 
(O), Claudin 4 (P), Occludin (Q) and Zonula occludens 1 (R) were assessed by 
quantitative RT-PCR in ileal samples obtained from all the patients and all the controls. 
Data are expressed a mean (SEM). A-D, F-J: original magnification x 250. Insert in A-C 
and F-G: original magnification x 630 
Figure 2. Occludin, Claudin 4 and Zonulin 1 tissue expression is altered on AS 
patients and modulated by intestinal bacteria. A-B: representative imaging showing 
Occludin expression in the gut of AS patients (A) and controls (B). C: higher numbers of 
Occludin positive cells were observed in healthy controls compared to AS. D-E: 
representative imaging showing Claudin 4 expression in the gut of AS patients (D) and 
controls (E). F: higher numbers of Claudin 4 positive cells were observed in healthy 
controls compared to AS. G: relative m-RNA levels of Zonulin 1 were assessed by RT-
PCR in the ileal samples obtained from all the AS patients and HC. H-I: representative 
imaging showing Zonulin 1 expression in the gut of AS patients (H) and controls (I). J: 
quantification of Zonulin 1 positive cells was performed in the ileal biopsies of all the 
patients and the controls showing higher numbers of Zonulin 1 positive cells in AS 
patients. K: the number of zonulin positive cells was significantly and directly correlated 
with the number of IL-8 positive cells. L: Caco-2 cells were incubated with bacteria isolated 
from ileal biopsies obtained from 5 AS patients and the modulation of Zonulin expression 
assessed by RT-PCR. Data are expressed as mean (SEM) of 5 independent experiments. 
A-B: original magnification x 630. D-E: original magnification x 250. H-I: original 
magnification x 400. Data are expressed as mean (SEM) 
Figure 3. Gut vascular barrier (GVB) in AS patients. A-C: relative m-RNA levels of VE-
Cadherin (A), JAM-1 (B) and PV1 (C) were assessed by RT-PCR in AS and HC ileal 
samples. D-F and G-I: representative confocal microscopy images showing CD31 and 
Occludin co-localization in HCs (D-F) and AS (G-I). J-M and N-Q: representative confocal 
microscopy images showing PV1, CD31 and GFAP co-localization in HCs (J-M) and AS 
(N-Q). D-Q: original magnification x 400. Data are expressed as mean (SEM) 
 Figure 4. Serum levels of Zonulin in AS patients and in vitro effects of zonulin on 
HUVEC and peripheral monocytes. A-B: mRNA expression of Occludin (A) and VE-
cadherin (B) was assessed in HUVEC cells treated or not with recombinant human zonulin 
by RT-PCR. Significant down-regulation of Occludin and VE-cadherin was observed in 
HUVEC after incubation with zonulin. C-D: Serum levels of zonulin were evaluated in 20 
AS patients and 20 controls (C) and correlated with LA/MA ratio (D). E-H: PBMC obtained 
from 5 AS patients (E) and 5 controls (G)  were incubated with recombinant zonulin and 
the percentage of CD163+cMAF+ cells evaluated by flow cytometry; percentages of AS 
(F) and controls (H) CD163+cMAF+ cells before and after zonulin stimulation. A-B: data 
are expressed as mean (SEM). C-D, F, H: data are expressed as individual data points. 
Figure 5. Intestinal bacterial products translocate into AS bloodstream and 
modulate monocytes behavior. A-C: serum levels of LPS (A), LPS-BP (B) and iFABP 
(C) are increased in the sera obtained from AS patients compared to  controls. D-F: 
percentages of CD14+ cells is reduced in PBMC from AS patients. D: representative dot 
plot showing the percentage of CD14+ cells gated on CD45 region)among PBMC in AS 
patients and controls, E: representative histogram showing CD14 MFI in AS and HCs. F: 
percentages of CD14+ cells in AS patients and controls. G-H: percentage of HLA-DR+ 
cells is reduced in PBMC from AS patients. G: representative dot plot showing the 
percentage of HLA-DR+ cells gated on monocytes region among PBMC in AS patients 
and controls, H: percentages of CD14+ cells in AS patients and controls. I-K: effects of 
monocytes stimulation with LPS alone, sCD14 alone or sCD14+LPS on CD14+ (H) and 
CD14- monocytes. Combination of LPS+sCD14 increased IL-23 production only in CD14- 
cells (I-J). K: representative dot plots showing the gating strategy and the percentage of IL-
23 expressing cells. Results are showed as mean (SEM) 
Figure 6. Ileal inflammation and dysbiosis in HLAB27 transgenic rats is modified by 
antibiotic treatment. A-C: representative images showing IL-23 staining in ileal samples 
obtaining from WT rats (A), HLA-B27 TG rats (B) and HLA-B27 TG rats after antibiotics 
treatment (C). D: semiquantitative evaluation of IL-23+ cells. E-F: representative images 
showing IL-23 staining in ileal samples obtaining from WT rats (E), HLA-B27 TG rats (F) 
and HLA-B27 TG rats after antibiotics treatment (G). H: semiquantitative evaluation of IL-
23+ cells. I-K: representative images showing Warthin starry staining for identifying 
bacteria in ileal samples obtaining from WT rats (I), HLA-B27 TG rats (J) and HLA-B27 TG 
rats after antibiotics treatment (K). Higher number of adhering and sometimes invading 
bacteria were observed in HLA-B27 rats (J and insert in J) L: semiquantitative evaluation 
of bacteria in rats ileal samples. A-C, E-G: I-K original magnification x250; J insert: original 
magnification x 630. Data are expressed as individual data points. 
Supplemental Figure 1. A-C: representative images showing IL-8 immunohistochemistry 
for IL-8 in HCs (A), in AS patients with acute (B) and chronic inflammation (C). D: 
semiquantitative evaluation of IL-8+ cells in HC, AS patients without intestinal 
inflammation, AS patients with acute and chronic inflammation and healthy controls. E-H: 
correlations between zonulin and tight junction proteins. E: correlation between claudin1 
and zonulin mRNA levels. F: correlation between claudin 4 and zonulin mRNA levels. G: 
correlation between occluding and zonulin mRNA expression. H: correlation between 
zonula occludens and zonulin mRNA expression. A-C: original magnification x250. 
Supplemental figure 2. Genetic factors, such as HLA-B27, may shape the composition of 
intestinal microbiome in AS patients resulting in gut dysbiosis. Dysbiosis induces the 
production of high amount of zonulin that acts, in turn, deeply altering the integrity of 
epithelial and vascular barriers. The resulting translocation into the systemic circulation of 
bacterial products may result in monocyte anergy (indicated by the down regulation of 
CD14 and HLA-DR). Zonulin is also released in the systemic circulation and may induce 
the expansion of M2 macrophages. 
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